Q2 2023 Holdings
Filed 2023-08-14 | 64 holdings | $1.8B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $415.2M | 8,142,100 | 23.3% |
| Ambrx Biopharma Inc | SPONSORED ADS | 02290A102 | $158.3M | 9,616,155 | 8.9% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $119.3M | 1,310,000 | 6.7% |
| Biomea Fusion Inc(BMEA) | COM | 09077A106 | $78.4M | 3,570,872 | 4.4% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $71.7M | 4,169,179 | 4.0% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $63.2M | 2,000,000 | 3.5% |
| Immuneering Corp(IMRX) | CLASS A COM | 45254E107 | $42.6M | 4,204,364 | 2.4% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $41.6M | 3,800,000 | 2.3% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $41.4M | 1,500,000 | 2.3% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $39.5M | 1,936,133 | 2.2% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $33.2M | 665,000 | 1.9% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $32.4M | 5,150,000 | 1.8% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $30.9M | 1,095,000 | 1.7% |
| Erasca Inc(ERAS) | COM | 29479A108 | $29.8M | 10,813,246 | 1.7% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $29.0M | 2,612,115 | 1.6% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $28.7M | 2,221,739 | 1.6% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $27.8M | 3,200,000 | 1.6% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $27.8M | 3,082,000 | 1.6% |
| Aerovate Therapeutics Inc | COM | 008064107 | $26.8M | 1,561,696 | 1.5% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $25.7M | 1,421,422 | 1.4% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $25.6M | 1,350,000 | 1.4% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $24.4M | 340,000 | 1.4% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $24.0M | 576,373 | 1.3% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $22.8M | 2,946,887 | 1.3% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $20.2M | 850,000 | 1.1% |
| Karuna Therapeutics Inc | COM | 48576A100 | $17.3M | 80,000 | 1.0% |
| Longboard Pharmaceuticals in | COM | 54300N103 | $17.3M | 2,353,141 | 1.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $17.3M | 868,550 | 1.0% |
| Axonics Inc(AXNX*) | COM | 05465P101 | $16.3M | 322,240 | 0.9% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $14.9M | 130,000 | 0.8% |
| Pharvaris N V(PHVS) | COM | N69605108 | $14.7M | 973,614 | 0.8% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $14.1M | 600,000 | 0.8% |
| Bridgebio Pharma Inc(BBIO)Put | COM | 10806X102 | $13.9M | 810,800 | 0.8% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $11.8M | 1,000,000 | 0.7% |
| Iveric BIO Inc(OPHTEUR)Call | COM | 46583P102 | $11.8M | 300,000 | 0.7% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $11.6M | 1,087,807 | 0.6% |
| Praxis Precision Medicines I | COM | 74006W108 | $10.9M | 9,500,000 | 0.6% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $10.4M | 550,000 | 0.6% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $10.0M | 225,000 | 0.6% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $9.9M | 600,000 | 0.6% |
| Lianbio | SPONSORED ADS | 53000N108 | $9.7M | 4,250,000 | 0.5% |
| Morphic Hldg Inc | COM | 61775R105 | $8.6M | 150,000 | 0.5% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $8.3M | 1,000,000 | 0.5% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $7.6M | 800,000 | 0.4% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $7.0M | 593,043 | 0.4% |
| Verve Therapeutics Inc | COM | 92539P101 | $6.6M | 350,000 | 0.4% |
| Rapt Therapeutics Inc(RAPTEUR) | COM | 75382E109 | $6.1M | 325,000 | 0.3% |
| Vigil Neuroscience Inc(VIGL) | COM | 92673K108 | $5.8M | 616,786 | 0.3% |
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $5.8M | 1,547,181 | 0.3% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $5.4M | 115,000 | 0.3% |